Early versus delayed erythropoietin for the anaemia of end-stage kidney disease

Author:

Coronado Daza Jorge1,Martí-Carvajal Arturo J2,Ariza García Amaury1,Rodelo Ceballos Joaquín3,Yomayusa González Nancy4,Páez-Canro Carol5,Loza Munárriz César6,Urrútia Gerard7

Affiliation:

1. Universidad de Cartagena; Facultad de Medicina, Departamento Médico, Grupo de Investigación Alta Tensión; Sede Zaragocilla, Campus de la Salud Cartagena Bolivar Colombia 130015

2. Iberoamerican Cochrane Network; Valencia Venezuela

3. University of Antioquia; Hospital Universitario San Vicente Fundacion, Servicio de Nefrologia; Calle 64 # 51 D 154 Bloque 3 Medellin Antioquia Colombia 05001000

4. Universidad Sanitas, Bogotá; Clínica Colsanitas. Grupo de Investigación Traslacional; Kra 31 125 A-23 Bogota Cundinamarca Colombia 11001000

5. Universidad Nacional de Colombia; Instituto de Investigaciones Clínicas, Facultad de Medicina; Bogota Colombia

6. Universidad Peruana Cayetano Heredia; Department of Nephrology; Hospital Cayetano Heredia Honorio Delgado 420 Lima Peru 31

7. CIBER Epidemiología y Salud Pública (CIBERESP); Iberoamerican Cochrane Centre - Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret, 167 Pavilion 18 (D-16a) Barcelona Catalonia Spain 08025

Publisher

Wiley

Subject

Pharmacology (medical)

Reference131 articles.

1. Morbidity and mortality in hemodialysis patients with and without erythropoietin treatment: a controlled study;Bahlmann;Contributions to Nephrology,1991

2. A multicenter clinical trial of epoetin beta for anemia of end-stage renal disease;Bennett;Journal of the American Society of Nephrology,1991

3. Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease;Berns;Kidney International,1999

4. Effect of normal v. anemic hematocrit on ambulatory blood pressure (ABP) in erythropoietin-treated hemodialysis (HD) patients [abstract];Berns;Journal of the American Society of Nephrology,1995

5. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin;Besarab;New England Journal of Medicine,1998

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3